From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at α4β2 nicotinic acetylcholine receptor-Reference-Cited by-同舟云学术

From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at α4β2 nicotinic acetylcholine receptor

Published:2017-01 Issue: Volume:125 Page:1132-1144
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Bolchi Cristiano,Bavo Francesco,Gotti Cecilia,Fumagalli Laura,Fasoli Francesca,Binda Matteo,Mucchietto Vanessa,Sciaccaluga Miriam,Plutino Simona,Fucile Sergio,Pallavicini Marco

Funder

Università degli Studi of Milan

fondazione Giancarlo Vollaro

fondazione Confalonieri

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference37 articles.

1. Recent developments in novel antidepressants targeting alpha4beta2 nicotinic acetylcholine receptors;Yu;J. Med. Chem.,2014

2. Discovery of highly potent and selective alpha4beta2 nicotinic acetylcholine receptor (NAChR) partial agonists containing an isoxazolylpyridine ether scaffold that demonstrate antidepressant-like activity;Yu;J. Med. Chem.,2012

3. Chemistry, pharmacology and behavioural studies identify chiral cyclopropanes as selective alpha4beta2 nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile;Zhang;J. Med. Chem.,2013